| Switchable lipids: conformational change for fast pH‐triggered cytoplasmic delivery W Viricel, A Mbarek, J Leblond Angewandte Chemie International Edition 54 (43), 12743-12747, 2015 | 98 | 2015 |
| Monodisperse polysarcosine-based highly-loaded antibody-drug conjugates W Viricel, G Fournet, S Beaumel, E Perrial, S Papot, C Dumontet, ... Chemical Science 10 (14), 4048-4053, 2019 | 70 | 2019 |
| Payload diversification: a key step in the development of antibody–drug conjugates L Conilh, L Sadilkova, W Viricel, C Dumontet Journal of Hematology & Oncology 16 (1), 3, 2023 | 56 | 2023 |
| Cationic switchable lipids: pH-triggered molecular switch for siRNA delivery W Viricel, S Poirier, A Mbarek, RM Derbali, G Mayer, J Leblond Nanoscale 9 (1), 31-36, 2017 | 54 | 2017 |
| Exatecan antibody drug conjugates based on a hydrophilic polysarcosine drug-linker platform L Conilh, G Fournet, E Fourmaux, A Murcia, EL Matera, B Joseph, ... Pharmaceuticals 14 (3), 247, 2021 | 38 | 2021 |
| Liposomes as gene delivery vectors for human placental cells L Valero, K Alhareth, J Espinoza Romero, W Viricel, J Leblond, A Chissey, ... Molecules 23 (5), 1085, 2018 | 26 | 2018 |
| Single stranded siRNA complexation through non-electrostatic interactions L Giraud, W Viricel, J Leblond, S Giasson Biomaterials 113, 230-242, 2017 | 4 | 2017 |
| Cytoplasmic signaling of polyinosinic-polycytidylic acid stimulates a quick and potent interferon response in primary macrophages N Dauletbaev, A Dintakurti, W Viricel, J Leblond-Chain, L Lands European Respiratory Journal 50 (suppl 61), 2017 | 2 | 2017 |
| Cytotoxicity of liposome-encapsulated polyinosinic-polycytidylic acid in primary human macrophages is only partially related to interferon-ß N Dauletbaev, A Dintakurti, Y Choi, M Cammisano, W Viricel, J Leblond, ... European Respiratory Journal 52 (suppl 62), 2018 | 1 | 2018 |
| Stimulation with polyinosinic-polycytidylic acid (poly (I: C)) encapsulated within novel pH-sensitive switchable liposomes leads to a faster and more potent interferon response N Dauletbaev, M Cammisano, W Viricel, SA Laurin, J Leblond-Chain, ... European Respiratory Journal 48 (suppl 60), 2016 | 1 | 2016 |
| MBK-103, a potent novel conjugation platform-based antibody-drug conjugate, changing therapeutic options in folate receptor alpha positive cancer patients W Viricel, L Conilh, E Leroy, JG Lafay, F Brune, LK Sadilkova, C Dumontet Cancer Research 83 (7_Supplement), 1544-1544, 2023 | | 2023 |
| Ligand-drug-conjugate comprising a single molecular weight polysarcosine W Viricel US Patent App. 16/758,638, 2020 | | 2020 |
| Monodisperse Polysarcosine-Based Antibody-Drug Conjugates W Viricel, G Fournet, S Beaumel, E Perrial, S Papot, C Dumontet, ... | | 2018 |
| Nanoparticules lipidiques pH-sensibles basées sur une bascule moléculaire pour la délivrance intracytoplasmique de siRNA W Viricel | | 2017 |
| Titelbild: Switchable Lipids: Conformational Change for Fast pH‐Triggered Cytoplasmic Delivery (Angew. Chem. 43/2015) W Viricel, A Mbarek, J Leblond Angewandte Chemie 127 (43), 12699-12699, 2015 | | 2015 |
| Cover Picture: Switchable Lipids: Conformational Change for Fast pH‐Triggered Cytoplasmic Delivery (Angew. Chem. Int. Ed. 43/2015) W Viricel, A Mbarek, J Leblond Angewandte Chemie International Edition 54 (43), 12517-12517, 2015 | | 2015 |
